期刊文献+

早期宫颈癌淋巴结转移危险因素分析 被引量:6

Analysis of Risk Factors of Lymph Node Metastases in Early Cervical Cancer
原文传递
导出
摘要 目的:研究早期宫颈癌淋巴结转移的危险因素,建立危险分层指数为个体化治疗提供依据。方法:采用单因素及多因素Logistic回归分析,对我院355例ⅠA-ⅡA期宫颈癌手术患者的临床病理资料进行回顾性分析。结果:355例宫颈癌患者盆腔淋巴结转移率为27.0%;多因素分析显示Figo分期(OR=1.90),浸润深度(OR=7.56)和肿瘤直径(OR=2.51)是淋巴结转移的危险因素;当逐一增加这些危险因素时,危险分层指数显示淋巴结转移危险度Ⅰ期为5%-50%,Ⅱ期为9%-65%。结论:在低危的Ⅰ期和高危的Ⅱ期宫颈癌中淋巴结转移风险存在相当大的跨度,使用危险分层模型能指导个体化治疗。 Objective: To investigate the risk factors for lymph node metastases and to construct a risk stratification index to provide the basis for making an individual therapy for the patients with cervical cancer. Methods: The clinicopathologie parameters in 355 patients with stage ⅠA-ⅡA cervical carcinoma were retrospectively analyzed. Uni- and multi-variate logistic regression analyses were used to calculate the predictive power of each risk factor. Results: Of the 355 patients with ⅠA-ⅡA cervical carcinoma, the rate of pelvic lymph node metastases was 27.0%. FIGO stage (OR=I. 90), depth of cervical stromal invasion(OR=7.56) and tumor diameters (OR= 2.56) were identified as significant risk factors for lymph node metastases in the multivariate analysis. The risk stratification index showed the risk for lymph node metastases gradually increasing from 5% to 50% and 9% to 65% in Ⅰ and Ⅱ stage cancers respectively, when adding the risk factors one by one. Conclusion: There is a considerable span in the risk for lymph node metastases between low risk Ⅰ and high risk Ⅱ stage cervical cancer. Using the risk stratification-model can provide references for individualized treatment.
出处 《武汉大学学报(医学版)》 CAS 北大核心 2014年第4期589-591,656,共4页 Medical Journal of Wuhan University
关键词 宫颈癌 淋巴结转移 危险因素 Cervical Cancer Lymph Node Metastases Risk Factor
  • 相关文献

参考文献13

  • 1Jemal A, Siegel R, Ward E, et al. Cancer statistics, 2008[J]. CA Cancer J Clin, 2008, 58(2) : 71-96.
  • 2Kornovski Y, Ismail E, Slavchev S, et al. Lymph node metastases and disease-free survival in cervical cancer patients[J]. Akush Ginekol (Sofiia), 2013; 52(2) : 9- 13.
  • 3Sakuragi N. Up-to-date management of lymph node metastasis and the role of tailored lymphadenectomy in cervical cancer[J]. Int J Clin Oncol, 2007, 12 (3): 165-175.
  • 4Li D, Cai J, Kuang Y, et al. Surgical-pathologic risk factors of pelvic lymph node metastasis in stage Ibl-IIb cervical cancer[J]. Aeta Obstetricia et Gynecol Scand, 2012, 91(7): 802-809.
  • 5Sun JR, Zhang YN, Sun XM, et al. Prediction model of pelvic lymph node metastasis in early stage cervical cancer and its clinical value[J]. Minerva Chirurgica, 2011, 66(6): 537-545.
  • 6潘秀玉,艾文霞,熊慧华,龚娥娥,吴茜子,朱涛,王常玉,奚玲.ⅠA~ⅡB期宫颈癌盆腔淋巴结转移高危因素的临床分析[J].华中科技大学学报(医学版),2011,40(6):686-691. 被引量:24
  • 7Takeda M, Sakuragi N, Okamoto K, et al. Preopera- tive serum SCC, CA125, and CA19-9 levels and lymph node status in squamous cell carcinoma of the uterine cervix[J]. Acta Obstet Gynecol Stand, 2002, 81(5): 451-457.
  • 8Piura B, Rabinovich A, Friger M. Number and distri- bution of pelvic lymph nodes and effect of surgical path- ologic factors on pelvic lymph node status in patients with early-stage cervical carcinoma treated with radical hysterectomy and pelvic lymph node dissection[J]. Eur J Gynaecol Oneol, 2006, 27(5): 463-466.
  • 9张海燕,盛修贵,钟艳,马志芳,马悦冰,刘乃富,陈月婷,王颖颖.早期宫颈癌盆腔淋巴结转移的分布[J].中华肿瘤杂志,2008,30(6):452-455. 被引量:17
  • 10Lee JM, Lee KB, Lee SK, et al. Pattern of lymph node metastasis and the optimal extent of pelvic lymph- adenectomy in FIGO stage IB cervical eancer[J]. J Ob- stet Gynaecol Res, 2007, 33(3): 288-293.

二级参考文献25

  • 1章文华,吴令英,白萍,李淑敏,张蓉,李斌,孙建衡,吴爱如.ⅠB期和ⅡA期宫颈癌患者的预后因素分析[J].中华肿瘤杂志,2004,26(8):490-492. 被引量:41
  • 2李斌,吴令英,李晓光,张询,章文华,高菊珍.早期子宫颈癌宫旁淋巴结的识别及其临床意义[J].中华妇产科杂志,2006,41(9):608-611. 被引量:30
  • 3Piver MS, Rutledge F, Smith JP. Five classes of extended hysterectomy for women with cervical cancer. Obstet Gynecol, 1974, 44:265-272.
  • 4Plentl AA, Friedman EA. Lymphatic system of the female genitalia: the morphologic basis of oncologic diagnosis and therapy. Major Probl Obstet Gynecol, 1971, 2 : 1-223.
  • 5Benedetti-Panici P, Maneschi F, D'Andrea G, et al. Early cervical carcinoma: the natural history of lymph node involvement redefined on the basis of thorough parametrectomy and giant section study. Cancer, 2000, 88:2267-2274.
  • 6Suprasert P, Srisomboon J, Kasamatsu T, et al. Radical hysterectomy for Ⅱ B cervical cancer: a review. Int J Gynecol Cancer, 2005, 15:995-1001.
  • 7Malur S, Krause N, Kohler C, et al. Sentinel lymph node detection in patients with cervical cancer. Gynecol Oncol, 2001, 80 : 254-257.
  • 8Curtin J P,Hoskins W J,Venkatraman E S,et al.Adjuvant chemotherapy versus chemotherapy plus pelvic irradiation for high-risk cervical cancer patients after radical hysterectomy and pelvic lymphadenectomy(RH-PLND):a randomized phase Ⅲ trial[J].Gynecol Oncol,1996,61(1):3-10.
  • 9Aoki Y,Sasaki M,Watanabe M,et al.High-risk group in node-positive patients with stage ⅠB,ⅡA,and ⅡB cervical carcinoma after radical hysterectomy and postoperative pelvic irradiation[J].Gynecol Oncol,2000,77(2):305-309.
  • 10Sankaranarayanan R.Overview of cervical cancer in the developing world.FIGO 6th Annual Report on the Results of Treatment in Gynecological Cancer[J].Int J Gynaecol Obstet,2006,95(Suppl 1):S205-S210.

共引文献37

同被引文献48

引证文献6

二级引证文献57

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部